Position in IDYA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,644,575
-$374,105 QoQ
Shares Held
49,357
-15.5% QoQ
Ownership
0.056%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 87.23585307048646.ToString("F0")%
Shared 0.ToString("F0")%
None 12.764146929513545.ToString("F0")%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Orion Porfolio Solutions, LLC holds $53,458,401 across 58 Biotechnology names. IDYA ranks #8 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
34,641 | $5,664,495 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
11,862 | $5,296,857 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
61,344 | $4,606,320 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
22,617 | $4,275,743 | |
| 5 | ARGX |
Argenx SE
|
3,730 | $2,723,832 | |
| 6 | INVA |
Innoviva, Inc.
|
89,973 | $2,096,370 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,537 | $1,851,513 | |
| 8 | IDYA |
IDEAYA Biosciences, Inc.
This page
|
49,357 | $1,644,575 |
All Filings in IDYA
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,644,575 | 49,357 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,018,680 | 58,394 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,481,094 | 54,432 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $938,017 | 44,625 | Shares | Sole | 2025-08-27 | |
| 2025-03-31 | $591,498 | 36,111 | Shares | Sole | 2025-08-01 | |
| 2024-12-31 | $456,663 | 17,769 | Shares | Sole | 2025-08-01 | |
| 2024-09-30 | $936,239 | 29,553 | Shares | Sole | 2025-07-31 | |
| 2024-06-30 | $1,232,185 | 35,095 | Shares | Sole | 2025-07-31 | |
| 2024-03-31 | $1,430,926 | 32,610 | Shares | Sole | 2025-07-31 | |
| No filing history on record for this holder in this stock. | ||||||